C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: a common founder and its geographical predilection.


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
04 2020
Historique:
received: 15 11 2019
accepted: 27 12 2019
pubmed: 10 2 2020
medline: 24 9 2020
entrez: 10 2 2020
Statut: ppublish

Résumé

Hexanucleotide repeat expansion in C9orf72 is defined as a major causative factor for familial amyotrophic lateral sclerosis (ALS). The mutation frequency varies dramatically among populations of different ethnicity; however, in most cases, C9orf72 mutant has been described on a common founder haplotype. We assessed its frequency in a study cohort involving 593 clinically and electrophysiologically defined ALS cases. We also investigated the presence of reported Finnish haplotype among the mutation carriers. The identified common haplotype region was further screened in 192 (carrying 2-6 G4C2 repeats) and 96 (≥7 repeats) control chromosomes. The G4C2 expansion was observed in 3.2% (19/593) of total cases where 9/19 (47.4%) positive cases belonged to the eastern region of India. Haplotype analysis revealed 11 G4C2-Ex carriers shared the common haplotype (haplo-A) background spanning a region of ∼90 kbp (rs895021-rs11789520) including rs3849942 (a well-known global at-risk loci with T allele for G4C2 expansion). The other 3 G4C2-Ex cases had a different haplotype (haplo-B) with core difference from haplo-A at G4C2-Ex flanking 31 kbp region between rs3849942 and rs11789520 SNPs (allele 'C' of rs3849942 which is a nonrisk allele). Out of other five G4C2-cases, four carried the risk allele T of rs3849942 while one harbored the non-risk allele. This study establishes the prevalence of C9orf72 expansion in Indian ALS cases providing further evidence for geographical predilection. The global core risk haplotype predominated C9orf72 expansion-positive ALS cases, yet the existence of a different haplotype suggests a second lineage (haplo B), which may have been derived from the Finnish core haplotype or may imply a unique haplotype among Asians. The association of risk haplotype with normal intermediate C9orf72 alleles reinforced its role in conferring instability to the C9orf72-G4C2 region. We thus present an effective support to interpret future burden of ALS cases in India.

Identifiants

pubmed: 32035847
pii: S0197-4580(19)30453-1
doi: 10.1016/j.neurobiolaging.2019.12.024
pii:
doi:

Substances chimiques

C9orf72 Protein 0
C9orf72 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

156.e1-156.e9

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Uzma Shamim (U)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Sakshi Ambawat (S)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Jyotsna Singh (J)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Aneesa Thomas (A)

Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.

Chevula Pradeep-Chandra-Reddy (C)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Varun Suroliya (V)

Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.

Bharathram Uppilli (B)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Shaista Parveen (S)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Pooja Sharma (P)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Shankar Chanchal (S)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Saraswati Nashi (S)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Veeramani Preethish-Kumar (V)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Seena Vengalil (S)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Kiran Polavarapu (K)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Muddasu Keerthipriya (M)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Niranjan Prakash Mahajan (NP)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Neeraja Reddy (N)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Priya Treesa Thomas (PT)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Arun Sadasivan (A)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Manjusha Warrier (M)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Malika Seth (M)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Sana Zahra (S)

Department of Psychiatric Social Work, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Aradhana Mathur (A)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India.

Deepti Vibha (D)

Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.

Achal K Srivastava (AK)

Department of Neurology, Neuroscience Centre, All India Institute of Medical Sciences, New Delhi, India.

Atchayaram Nalini (A)

Neurology Department, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Mohammed Faruq (M)

Genomics and Molecular Medicine Division, CSIR - Institute of Genomics and Integrative Biology, New Delhi, India. Electronic address: faruq.mohd@igib.res.in.

Articles similaires

Humans Emergency Service, Hospital Child Child, Preschool Infant
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis
Humans Female Male Aged Respiratory Tract Infections

Classifications MeSH